MoneyWorks4Me

Gland Pharma informs about analyst meet

24 May 2023 Evaluate
Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that it enclosed the schedule of the Analyst/ Institutional Investor Meetings with the Company as on 24th May 2023 and 25th May 2023. More details enclosed.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1861.70
Dr. Reddys Labs. 1216.10
Cipla 1378.15
Lupin 2118.00
Zydus Lifesciences 1170.00
View more..